SoMex Research & Health
Pvt. Ltd.
+91-141-2504996           
banner11 banner22 banner33 banner44

News & Events


Dacomatinib is now available in India for EGFR Positive Lung Cancer. This drug is better than first generation gefitinib and second generation afatinib in many senses.

(22-June-2020)
Dacomatinib is now available in India for EGFR Positive Lung Cancer. This drug is better than first generation gefitinib and second generation afatinib in many senses.



Other News